Search details
1.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33104215
2.
The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy.
J Oncol Pharm Pract
; 29(1): 45-51, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-34816754
3.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32649981
4.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32965680
5.
Upsetting the apple CAR-T (chimeric antigen receptor T-cell therapy) - sustainability mandates USA innovation.
Br J Haematol
; 190(6): 851-853, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32358811
6.
Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.
J Am Acad Dermatol
; 83(3): 762-772, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-31654664
7.
A Practical Guide to Gynecologic and Reproductive Health in Women Undergoing Hematopoietic Stem Cell Transplant.
Biol Blood Marrow Transplant
; 25(11): e331-e343, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31394266
8.
Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 216-222, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30292745
9.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30342913
10.
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(2): e46-e54, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30481594
11.
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): e145-e154, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30521975
12.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 480-487, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30423481
13.
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 362-368, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30287390
14.
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
Blood
; 130(9): 1156-1164, 2017 08 31.
Article
in English
| MEDLINE | ID: mdl-28674027
15.
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Transpl Infect Dis
; 21(5): e13145, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31301099
16.
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(3): 460-466, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29197677
17.
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(2): 228-241, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28939455
18.
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Cancer
; 124(4): 816-825, 2018 02 15.
Article
in English
| MEDLINE | ID: mdl-29125192
19.
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
Blood
; 127(20): 2427-38, 2016 05 19.
Article
in English
| MEDLINE | ID: mdl-26884374
20.
Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.
Biol Blood Marrow Transplant
; 23(2): 184-192, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27818318